News | September 13, 2011

Mediso Introduces First Integrated Whole-Body Preclinical PET/MRI Imager

September 13, 2011 – Mediso Medical Imaging Systems announced at the World Molecular Imaging Congress (WMIC) the launching of the new nanoScan positron emission tomography/magnetic resonance imaging (PET/MRI), in vivo molecular and preclinical imager.

The PET subsystem, equipped with the new Tera-Tomo 3-D reconstruction engine, performs quantitative PET studies with an average resolution of 700 microns. Due to the advanced graphics processing unit (GPU) based on the fly system matrix generation principle and the physical corrections in 3-D PET reconstruction, a uniform resolution is achieved throughout the field-of-view.

Using corrections for a variety of physical factors, a quantitative three-dimensional PET reconstruction has been developed and applied by Mediso and their academic collaborators. Some of these factors include detector response, detector attenuation and scatter, object attenuation and scatter, random, dead time and positron range.

The compact shielded MRI platform from Aspect imaging utilizes a high-performance 1T magnet with zero magnetic fringe field outside the magnet. It provides high spatial resolution of down to 100 micrometers (?m), with high soft tissue contrast required for anatomical/morphological imaging. The permanent magnet platform provides a maintenance-free MRI solution with a small footprint and easy installation. It is optimized to perform fast, high-throughput imaging of a variety of applications and preclinical studies.

The new platform can be applied for imaging and quantification in the following areas: oncology and tumor biology, regenerative medicine, PET development of radiotracers, receptor studies in neuroscience, inflammation and immunology, infectious diseases, animal model development and phenotyping and multi- modal imaging and contrast agent development.

The system is designed for any facility and for use by any operator. There is no need for any additional magnetic or RF shielding and no special site preparation is required for the installation of the equipment.

The first device was installed at the prestigious Karolinska Institute in April 2011 and is being used by Prof. Christer Halldin and in the core imaging laboratories of Professor Balázs Gulyás. It was the optimal imaging choice for Halldin, whose research requires the highest level PET radiotracer technology along with support and co-registration with high-resolution MRI images.

“The nanoScan PM combines anatomical and molecular imaging modalities using a state-of-the-art PET technology with cutting edge resolution and sensitivity and a unique user friendly MRI imaging for pre-clinical studies,” says Halldin, professor, director of Karolinska Institute PET Center.

For more information: www.mediso.com

Related Content

News | Business | September 19, 2017
September 19, 2017 — Invicro LLC, a provider of imaging services and software for research and drug development, anno
Dual-Agent PET/MR With Time of Flight Detects More Cancer

Tc-99m MDP bone scan (left) is negative for osseous lesions. NaF/FDG PET/MRI (right and second slide) confirms absence of bone metastases, but shows liver metastases. Image courtesy of Stanford University.

News | PET-MRI | June 20, 2017
Simultaneous injections of the radiopharmaceuticals fluorine-18 fluorodeoxyglucose (18F-FDG) and 18F-sodium fluoride (...
PET/CT

The Philips Ingenuity TF PET/CT system leverages multiple technologies.

Feature | Radiation Oncology | May 05, 2017 | By Lola Koktysh
The continuum of personalized care, covering individualized prevention and therapy, translates into multiple changes to...
Northwestern Memorial Hospital, MR-PET scanner, first in Illinois, Siemens Biograph mMR
News | PET-MRI | March 31, 2017
Northwestern Memorial Hospital is now home to the Chicago area's first combined magnetic resonance (MRI) and positron...
University of Arizona, Cubresa, NuPET, PET/MRI scanner installed, tumor assessment

Panel A shows a flank A549 lung tumor in a nude mouse with combined 18F-FDG PET uptake (signal intensity in color) and T2-weighted anatomical MRI (grayscale). Panel B shows a similar tumor image with a relative permeability map for the tumor (color code) overlaid on a corresponding anatomical MRI reference. Regions identified as necrotic were not included in the DCE MRI analysis. Image courtesy of the University of Arizona Department of Medical Imaging.

News | PET-MRI | October 13, 2016
Cubresa Inc. recently announced the successful installation of their compact positron emission tomography (PET) scanner...
PET/CT

There is a growing focus on early diagnosis and prevention. Here, PET/CT imaging is used to look inside the stress center of the brain.

Feature | Imaging | September 07, 2016 | By Kirill Shalyaev, Ph.D.
Advanced imaging and hybrid modalities, such as computed tomography (CT), magnetic resonance imaging (MRI), positron...
PET, PET imaging, PET-CT, FDG PET, PET cancer assessment, nuclear imaging, molecular imaging

A PET-CT head and neck cancer scan showing various image reconstructions. The top left image is the separate CT scan showing the anatomy. The top right scan shows the fused PET and CT scans with false color added to help interpret the image. The bottom left scan is an initial FDG PET image showing tracer hot spots in the neck and a lymph node in the right jaw due to cancer. The right bottom image is a delayed enhancement scan showing tracer uptake over time, with normal hot spots in the bladder, kidneys, testicles and brain, which normally have higher metabolic activity. The low-grade gray shading of the anatomy is due to the normal cellular metabolism uptake of the FDG throughout the body. 

Feature | PET Imaging | July 26, 2016 | Dave Fornell
Positron emission tomography (PET) is a nuclear imaging technology (also referred to as molecular imaging) that enabl
News | Prostate Cancer | June 17, 2016
Decatur Memorial Hospital, Decatur, Ill., is now offering C-11 choline positron emission tomography (PET)/computed...
PET, PET imaging, PET-CT, FDG PET, PET cancer assessment

A PET-CT head and neck cancer scan showing various image reconstructions. The top left image is the separate CT scan showing the anatomy. The top right scan shows the fused PET and CT scans with false color added to help interpret the image. The bottom left scan is an initial FDG PET image showing tracer hot spots in the neck and a lymph node in the right jaw due to cancer. The right bottom image is a delayed enhancement scan showing tracer uptake over time, with normal hot spots in the bladder, kidneys, testicles and brain, which normally have higher metabolic activity. The low-grade gray shading of the anatomy is due to the normal cellular metabolism uptake of the FDG throughout the body. 

Feature | PET Imaging | June 03, 2016 | Dave Fornell
Positron emission tomography (PET) is a nuclear imaging technology (also referred to as molecular imaging) that enabl

Early detection of cancer lesions with the latest generation of PET/CT scanners supports improved patient management. Yet much of PET’s potential, particularly for following patients and as a component in PET/MR, remains unrealized. (Image courtesy of Siemens Healthcare and the University of Tennessee, Knoxville)

Feature | Imaging | April 29, 2016 | Greg Freiherr
Adopting medical technology because it is new or novel lost its luster a long time ago. It is little wonder then that...
Overlay Init